title: PARP inhibitors: a treatment option for AML?
authors.affiliation: Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA.
authors.forename: Lan
authors.initials: L
authors.lastname: Wang
authors.affiliation: Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA.
authors.forename: Pierre-Jacques
authors.identifier: http://orcid.org/0000-0002-2484-6161
authors.initials: PJ
authors.lastname: Hamard
authors.affiliation: Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA.
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Nimer
mesh_terms: D000818:Animals; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000378:metabolism*; D009857:Oncogenes; D000067856:Poly(ADP-ribose) Polymerase Inhibitors / Q000627:therapeutic use*; D014157:Transcription Factors / Q000378:metabolism*
chemical_list: D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D014157:Transcription Factors